Sarepta Therapeutics Inc. (SRPT)
106.02
-2.39 (-2.20%)
At close: Feb 21, 2025, 3:57 PM
106.22
0.19%
After-hours: Feb 21, 2025, 03:59 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 | FY95 |
| Net Income | -535.98M | -703.49M | -418.78M | -554.13M | -715.08M | -361.92M | -50.69M | -267.26M | -220.03M | -135.79M | -111.98M | -121.29M | -2.32M | -32.18M | -25.16M | -23.95M | -27.17M | -31.07M | -16.68M | -24.78M | -14.62M | -29.36M | -26.93M | -9.24M | -8.3M | -26.7M | -3.6M | -2.1M | -2.6M |
| Depreciation & Amortization | 44.4M | 41.86M | 38.02M | 26.91M | 30.55M | 12.24M | 8.09M | 5.61M | 5.25M | 3.69M | 1.28M | 1.52M | 1.3M | 1.46M | 1.38M | 1.47M | 2.01M | 2.09M | 2M | 1.89M | 1.48M | 1.33M | 556.47K | 416.5K | 300K | 200K | 500K | 500K | 500K |
| Stock-Based Compensation | 182.51M | 233.02M | 113.94M | 108.07M | 78.6M | 50.13M | 30.46M | 29.96M | 32.12M | 20.34M | 11.13M | 3.08M | 3.13M | 3.17M | 2.37M | 165.88K | 312.64K | 525.13K | 394.23K | 421.63K | 489.66K | 489.66K | 120K | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | -97.54M | -74.62M | 13.96M | 583.1M | -102.09M | -136.64M | -15.35M | -9.01M | 162.25M | 210.93M | 234.84M | 115.02M | 24.58M | -350K | 17.8M | 9.76M | 18.96M | 2.9K | 45.91M | 100.55K | -2.9M | 805.61K | -894.79K | -305.29K | 400K | 200K | 100K | 100K | 60K |
| Other Non-Cash Items | 289.16M | 142.73M | -94M | -38.09M | 224.79M | 20.19M | -122.32M | 1.27M | 367K | 12K | 11.13M | 92.3M | -33.02M | 11.5M | 9.2M | 12.39M | 775.7K | 6.78M | 430.09K | 508.58K | -3.29M | 5.12M | 12.76M | n/a | -100K | 19.6M | n/a | -100K | 260K |
| Deferred Income Tax | n/a | n/a | 15.81M | 10.64M | -8.45M | -1.41M | -83K | 373K | 849K | 5.34M | 11.49M | n/a | 299K | 1.18M | 475K | 417.74K | -253.26K | -332.76K | -394.23K | -421.63K | -489.66K | -489.66K | -120K | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -481.09M | -39.47M | -98.17M | 554.06M | -66.88M | -107.89M | -97.46M | -15.77M | 31.98M | -22.14M | 12.27M | -5.3M | 6.93M | -350K | 2.93M | -2.82M | -358.37K | 1.4M | -420.86K | -1.4M | -1.05M | 2.65M | 783.49K | -305.29K | 400K | 200K | 100K | 100K | 60K |
| Operating Cash Flow | -500.99M | -325.35M | -443.17M | 107.47M | -456.46M | -388.66M | -232M | -245.82M | -149.47M | -128.54M | -64.69M | -29.69M | -23.68M | -15.21M | -8.8M | -12.34M | -24.68M | -20.61M | -14.67M | -23.78M | -17.48M | -20.26M | -12.82M | -9.13M | -7.6M | -6.7M | -3M | -1.6M | -1.78M |
| Capital Expenditures | -76.11M | -30.82M | -38.49M | -82.2M | -62.71M | -64.34M | -21.21M | -6.87M | -4.83M | -26.82M | -3.77M | -1.15M | -2.31M | -1.95M | -1.99M | -1.22M | -2.13M | -1.45M | -1.47M | -1.07M | -1.64M | -2.78M | -4.18M | -813.19K | -200K | -2.3M | -300K | -100K | -270K |
| Acquisitions | n/a | n/a | n/a | n/a | -172.56M | 3.19M | -9.21M | 1.52M | 1.43M | 1.38M | n/a | n/a | n/a | n/a | n/a | -11.38K | 857.21K | 686.61K | 397.08K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -2.05B | -1.94B | -29.99M | -1.33B | -1.19B | -1.17B | -589.52M | -195.43M | -172.7M | -274.37M | -7.9M | n/a | n/a | -7K | n/a | -10.21K | -110.42K | -14.97M | -13.14M | -13.12M | -44.42M | -19.1M | -8.11M | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 1.87B | 923.22M | 466M | 1.19B | 1.72B | 865.81M | 306.92M | 112.1M | 185.94M | 142.16M | n/a | n/a | n/a | n/a | 111K | 859.42K | 12.81M | 14.44M | 3.69M | 35.49M | 31M | 19.93M | n/a | n/a | n/a | n/a | n/a | 200K | n/a |
| Other Investing Acitivies | 90.76M | -2.43M | 97.89M | 104.57M | 518.91M | -3.19M | 134.22M | -1.52M | -1.43M | -1.38M | -7.9M | -1.04M | -1.13M | n/a | -1.06M | -859.42K | -857.21K | -686.61K | -397.08K | -462.59K | -397.13K | -453.4K | -475.98K | -282.56K | -300K | -300K | -200K | n/a | 20K |
| Investing Cash Flow | -165.8M | -1.05B | 495.41M | -121.72M | 286.73M | -370.49M | -178.81M | -90.19M | 8.41M | -159.03M | -11.67M | -1.15M | -2.31M | -1.96M | -1.88M | -1.24M | 10.58M | -1.99M | -10.92M | 20.84M | -15.46M | -2.4M | -12.77M | -1.1M | -500K | -2.6M | -500K | 100K | -250K |
| Debt Repayment | n/a | 304.17M | n/a | 291.15M | 245.63M | -33.48M | 584.95M | -7.6M | 17.4M | -94K | -89K | -85K | -81K | -77K | -74K | -113K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -300K | n/a | 860K |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 125M | -71.66M | 13.04M | 79.12M | 31.57M | 563.63M | -50.83M | 20.93M | 10.49M | 9.75M | -226K | n/a | n/a | n/a | n/a | 106.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 100K | -100K | 860K |
| Financial Cash Flow | 125M | 232.51M | 561.57M | 682.32M | 642.55M | 530.15M | 888.08M | 378.13M | 147.81M | 104.16M | 145.67M | 178.6M | 32.3M | 2.48M | 47.77M | -31.89K | 18.74M | 8.16M | 43.53M | 7.07M | 35.08M | 21.98M | 10.76M | 27.44M | 8.2M | 200K | 18.2M | 3.9M | 860K |
| Net Cash Flow | -541.79M | -1.14B | 613.81M | 668.07M | 472.82M | -229M | 477.27M | 42.12M | 6.75M | -183.41M | 69.3M | 147.76M | 6.32M | -14.69M | 37.08M | -13.61M | 4.64M | -14.44M | 17.94M | 4.13M | 2.14M | -684.49K | -14.83M | 17.22M | 200K | 200K | 18.2M | 3.9M | -1.17M |
| Free Cash Flow | -588.34M | -356.17M | -481.66M | 25.26M | -519.18M | -453M | -253.21M | -252.69M | -154.3M | -155.36M | -68.47M | -30.84M | -25.98M | -17.16M | -10.79M | -13.56M | -26.8M | -22.07M | -16.14M | -24.85M | -19.12M | -23.04M | -17M | -9.94M | -7.8M | -9M | -3.3M | -1.7M | -2.05M |